Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 13 | 2022 | 294 | 3.650 |
Why?
|
| Inflammatory Bowel Diseases | 8 | 2023 | 90 | 3.140 |
Why?
|
| Intestinal Mucosa | 9 | 2020 | 232 | 2.050 |
Why?
|
| Colon | 8 | 2023 | 163 | 1.740 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 79 | 1.670 |
Why?
|
| Sleep | 5 | 2018 | 322 | 1.520 |
Why?
|
| Intestinal Absorption | 3 | 2015 | 42 | 1.360 |
Why?
|
| Cell Membrane Permeability | 3 | 2015 | 59 | 1.360 |
Why?
|
| Melatonin | 5 | 2016 | 98 | 1.230 |
Why?
|
| Work Schedule Tolerance | 2 | 2020 | 40 | 1.200 |
Why?
|
| Liver Diseases, Alcoholic | 3 | 2015 | 46 | 1.080 |
Why?
|
| Endotoxemia | 3 | 2015 | 30 | 1.030 |
Why?
|
| Circadian Clocks | 3 | 2022 | 35 | 1.030 |
Why?
|
| Colitis | 2 | 2023 | 41 | 0.890 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 12 | 0.860 |
Why?
|
| Mercaptopurine | 1 | 2023 | 3 | 0.860 |
Why?
|
| Ethanol | 7 | 2022 | 139 | 0.830 |
Why?
|
| Colitis, Ulcerative | 4 | 2022 | 71 | 0.760 |
Why?
|
| Feeding Behavior | 2 | 2019 | 101 | 0.750 |
Why?
|
| Gastrointestinal Tract | 2 | 2011 | 60 | 0.700 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 37 | 0.700 |
Why?
|
| Jet Lag Syndrome | 1 | 2018 | 16 | 0.630 |
Why?
|
| Period Circadian Proteins | 3 | 2021 | 25 | 0.610 |
Why?
|
| Sleep Hygiene | 1 | 2017 | 2 | 0.600 |
Why?
|
| Chronobiology Disorders | 1 | 2017 | 14 | 0.590 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 23 | 0.540 |
Why?
|
| Intestine, Small | 1 | 2016 | 34 | 0.530 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2016 | 41 | 0.520 |
Why?
|
| Mice | 8 | 2023 | 1683 | 0.510 |
Why?
|
| Humans | 27 | 2023 | 30959 | 0.480 |
Why?
|
| Permeability | 5 | 2021 | 139 | 0.480 |
Why?
|
| Crohn Disease | 2 | 2011 | 46 | 0.470 |
Why?
|
| Animals | 11 | 2023 | 4722 | 0.460 |
Why?
|
| Male | 20 | 2022 | 16425 | 0.460 |
Why?
|
| Radiation Injuries | 1 | 2013 | 35 | 0.440 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 90 | 0.420 |
Why?
|
| Intestines | 4 | 2021 | 115 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 3 | 2023 | 466 | 0.400 |
Why?
|
| Wine | 1 | 2011 | 8 | 0.390 |
Why?
|
| Adult | 12 | 2020 | 8924 | 0.380 |
Why?
|
| CLOCK Proteins | 1 | 2011 | 28 | 0.370 |
Why?
|
| Feces | 3 | 2023 | 117 | 0.340 |
Why?
|
| Alcoholism | 2 | 2022 | 85 | 0.330 |
Why?
|
| Sleep Wake Disorders | 1 | 2011 | 149 | 0.330 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2022 | 211 | 0.310 |
Why?
|
| Middle Aged | 11 | 2020 | 10192 | 0.310 |
Why?
|
| Female | 13 | 2020 | 16965 | 0.290 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 2 | 2016 | 10 | 0.260 |
Why?
|
| Time Factors | 3 | 2019 | 1672 | 0.240 |
Why?
|
| HIV Infections | 3 | 2018 | 890 | 0.240 |
Why?
|
| Photoperiod | 2 | 2021 | 47 | 0.230 |
Why?
|
| Young Adult | 6 | 2018 | 2060 | 0.230 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 782 | 0.230 |
Why?
|
| Dextran Sulfate | 1 | 2023 | 13 | 0.220 |
Why?
|
| Thioguanine | 1 | 2023 | 3 | 0.220 |
Why?
|
| Azathioprine | 1 | 2023 | 9 | 0.220 |
Why?
|
| Chronotherapy | 1 | 2023 | 9 | 0.220 |
Why?
|
| Cross-Over Studies | 1 | 2023 | 72 | 0.210 |
Why?
|
| Mindfulness | 1 | 2022 | 34 | 0.200 |
Why?
|
| Choline | 1 | 2022 | 7 | 0.200 |
Why?
|
| Osteogenesis | 1 | 2022 | 107 | 0.200 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2021 | 15 | 0.190 |
Why?
|
| Luciferases | 1 | 2021 | 24 | 0.190 |
Why?
|
| Pilot Projects | 1 | 2023 | 429 | 0.190 |
Why?
|
| Risk Factors | 3 | 2022 | 2586 | 0.180 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 1210 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2023 | 1897 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 213 | 0.170 |
Why?
|
| Colonic Polyps | 1 | 2019 | 26 | 0.170 |
Why?
|
| Immunity, Mucosal | 2 | 2019 | 32 | 0.170 |
Why?
|
| Obesity | 1 | 2022 | 307 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2018 | 22 | 0.160 |
Why?
|
| Case-Control Studies | 1 | 2020 | 660 | 0.150 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 164 | 0.150 |
Why?
|
| Bisacodyl | 1 | 2018 | 2 | 0.150 |
Why?
|
| Cathartics | 1 | 2018 | 4 | 0.150 |
Why?
|
| Isotonic Solutions | 1 | 2018 | 11 | 0.150 |
Why?
|
| Immunologic Factors | 1 | 2018 | 42 | 0.150 |
Why?
|
| Motor Activity | 1 | 2021 | 370 | 0.150 |
Why?
|
| Shift Work Schedule | 1 | 2017 | 6 | 0.150 |
Why?
|
| Ascorbic Acid | 1 | 2018 | 35 | 0.150 |
Why?
|
| Organoids | 1 | 2017 | 8 | 0.150 |
Why?
|
| Stem Cells | 1 | 2017 | 49 | 0.150 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 59 | 0.140 |
Why?
|
| Biomarkers | 3 | 2016 | 733 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2018 | 144 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 10 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 82 | 0.130 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 14 | 0.130 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 1009 | 0.120 |
Why?
|
| Hepatitis B Vaccines | 1 | 2014 | 8 | 0.120 |
Why?
|
| Bacterial Translocation | 1 | 2014 | 36 | 0.120 |
Why?
|
| Hepatitis B | 1 | 2014 | 20 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2015 | 101 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 106 | 0.120 |
Why?
|
| Vaccination | 1 | 2014 | 48 | 0.120 |
Why?
|
| Inflammation | 1 | 2017 | 362 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 284 | 0.120 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2014 | 64 | 0.110 |
Why?
|
| Disease Progression | 2 | 2022 | 830 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 135 | 0.110 |
Why?
|
| Liver | 1 | 2014 | 184 | 0.110 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2012 | 6 | 0.100 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2012 | 9 | 0.100 |
Why?
|
| Portal Vein | 1 | 2012 | 42 | 0.100 |
Why?
|
| Lactulose | 1 | 2011 | 8 | 0.100 |
Why?
|
| Sucrose | 1 | 2011 | 17 | 0.100 |
Why?
|
| Mannitol | 1 | 2011 | 12 | 0.100 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2011 | 8 | 0.100 |
Why?
|
| Venous Thromboembolism | 1 | 2012 | 40 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2018 | 3658 | 0.100 |
Why?
|
| Caco-2 Cells | 1 | 2011 | 55 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2022 | 91 | 0.090 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 128 | 0.090 |
Why?
|
| Prognosis | 1 | 2013 | 919 | 0.090 |
Why?
|
| Remission, Spontaneous | 1 | 2010 | 9 | 0.090 |
Why?
|
| Saliva | 1 | 2010 | 56 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1133 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 468 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 5189 | 0.080 |
Why?
|
| Rats | 1 | 2011 | 873 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2019 | 28 | 0.080 |
Why?
|
| Aged | 3 | 2018 | 10047 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2010 | 716 | 0.070 |
Why?
|
| Biopsy | 2 | 2018 | 249 | 0.070 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 10 | 0.050 |
Why?
|
| Methylamines | 1 | 2022 | 4 | 0.050 |
Why?
|
| Lyases | 1 | 2022 | 8 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 18 | 0.050 |
Why?
|
| Leptin | 1 | 2022 | 24 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2022 | 323 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 144 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2022 | 254 | 0.040 |
Why?
|
| Butyrates | 1 | 2019 | 24 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2019 | 26 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 261 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 99 | 0.040 |
Why?
|
| Electrolytes | 1 | 2018 | 14 | 0.040 |
Why?
|
| Transcription Factor HES-1 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Keratin-20 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Jejunum | 1 | 2017 | 12 | 0.040 |
Why?
|
| Chromogranin A | 1 | 2017 | 12 | 0.040 |
Why?
|
| Occludin | 1 | 2017 | 13 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Cadherins | 1 | 2017 | 37 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2017 | 31 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 120 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2018 | 53 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2017 | 31 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2017 | 41 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 697 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 225 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 246 | 0.040 |
Why?
|
| Ileum | 1 | 2015 | 25 | 0.030 |
Why?
|
| Dysbiosis | 1 | 2015 | 72 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2014 | 11 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 16 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 310 | 0.030 |
Why?
|
| Central Nervous System Depressants | 1 | 2014 | 24 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 74 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 133 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2014 | 134 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 44 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2014 | 91 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 158 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 156 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 549 | 0.030 |
Why?
|
| Prevalence | 1 | 2014 | 500 | 0.030 |
Why?
|
| Microbiota | 1 | 2014 | 130 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 35 | 0.030 |
Why?
|
| Adolescent | 1 | 2018 | 2399 | 0.020 |
Why?
|
| Chicago | 1 | 2014 | 943 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 407 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3806 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 817 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 991 | 0.020 |
Why?
|